Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gustavo Eduardo Velasquez, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Gustavo Velasquez and Meredith Brooks.
Gustavo Velasquez
Connection Strength
0.487
Meredith Brooks
  1. Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis. Am J Respir Crit Care Med. 2019 05 01; 199(9):1167-1168.
    View in: PubMed
    Score: 0.203
  2. Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2018 09 01; 198(5):657-666.
    View in: PubMed
    Score: 0.194
  3. Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis. Antimicrob Agents Chemother. 2017 08; 61(8).
    View in: PubMed
    Score: 0.090
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.